STOCK TITAN

Rallybio Corporation - $RLYB STOCK NEWS

Welcome to our dedicated page for Rallybio Corporation news (Ticker: $RLYB), a resource for investors and traders seeking the latest updates and insights on Rallybio Corporation stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Rallybio Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Rallybio Corporation's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.05%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.72%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.82%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.09%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.09%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.05%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.98%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.1%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.07%
Tags
Rallybio Corporation

Nasdaq:RLYB

RLYB Rankings

RLYB Stock Data

69.22M
20.76M
5.62%
87.18%
3.47%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States of America
NEW HAVEN

About RLYB

rallybio is a privately-held early-stage biotechnology company incorporated in january 2018. our ambition is to create a world-leading biotechnology organization that transforms the lives of patients with devastating disease, built around people with an outstanding track record in pharmaceutical research and development. we will work on highly-promising drug candidates that have strong biological rationales and that can be addressed using the well-validated therapeutic modalities of small molecules, engineered proteins, and antibodies. rallybio’s founders are seasoned leaders from the biopharma industry with a wide breadth of research, development, and financial experience. the company is based in farmington, ct, at the university of connecticut’s technology incubation program. we are assembling a small team of people with an outstanding track record in pharmaceutical research and development to search for and evaluate assets using a series of robust clinical and commercial filters tha